Home › Baarmoederhalskanker › New York › New York City
Baarmoederhalskanker klinische studies in New York City, NY
19 studies voor Baarmoederhalskanker zoeken deelnemers op locaties in en rond New York City (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
RekruterenFase 1
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- NYU Langone Medical Center - Perlmutter Cancer Center (NYU Cancer Institute), New York
- Icahn School of Medicine at Mount Sinai, New York
- en nog 2
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruterenFase 2
- Memorial Sloan Kettering Hospital, New York
Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer
RekruterenFase 4
- Columbia University Medical Center - Herbert Irving Pavilion, New York
- IP Address: Columbia University Medical Center/New York Presbyterian Hospital Research Pharmacy, New York
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
RekruterenFase 3
- Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 6009), New York
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruterenFase 1
- Memorial Sloan Kettering Cancer Center Head Neck Services, New York
A Study of Ivonescimab in People With Endometrial and Cervical Cancers
RekruterenFase 2
- Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
GI-101/GI-101A as a Single Agent or in Combination With Pembrolizumab or Lenvatinib in Advanced Solid Tumors
RekruterenFase 1/2
- Tisch Cancer Institute (TCI), Icahn School of Medicine, New York
- Columbia University, New York
Study of Volrustomig as Monotherapy or in Combination With Anti- Cancer Agents in Participants With Advanced/Metastatic Solid Tumors
RekruterenFase 2
- Research Site, New York
Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
RekruterenFase 1
- Laura & Isaac Perlmutter Cancer Center at NYU Langone Health, New York
A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
RekruterenFase 1
- New York University (NYU) Clinical Cancer Center, New York
- David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
A Study of STRO-004 in Adults With Refractory/Recurrent Metastatic Cancer
RekruterenFase 1
- Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
RekruterenFase 1/2
- NYU Langone Health, New York
- Icahn School of Medicine At Mount Sinai Prime, New York
A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer
Rekruteren
- Laura and Issac Perlmutter Cancer Center at NYU Langone-East 34th Street, New York
- Laura and Issac Perlmutter Cancer Center at NYU Langone, New York
- NYU Langone Medical Center (Tisch Hospital), New York
- en nog 3
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
RekruterenFase 1/2
- Memorial Sloan Kettering Cancer Center, New York
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
RekruterenFase 1
- North Shore Hematology Oncology Associates P.C. DBA New York Cancer and Blood Specialists, New York
- Columbia University Irving Medical Center, New York
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
RekruterenFase 1/2
- Research Site 107, New York
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruterenObservatieonderzoek
- Massive Bio SYNERGY-AI site, New York
Circulating Human Papilloma Virus (HPV) DNA for the Screening and Surveillance of Gynecologic Cancers
Rekruteren
- Lenox Hill Hospital, New York
NYSCF Scientific Discovery Biobank
RekruterenObservatieonderzoek
- New York Stem Cell Foundation Research Institute, New York
Baarmoederhalskanker studies in andere steden
- Houston, TX34 studies
- Nashville, TN19 studies
- Boston, MA18 studies
- Arlington, VA16 studies
- Los Angeles, CA16 studies
- San Antonio, TX14 studies
- St. Louis, MO13 studies
- Dallas, TX13 studies
- Orlando, FL12 studies
- Chicago, IL12 studies
- Columbus, OH11 studies
- Atlanta, GA11 studies
Andere studies in New York City
- Borstkanker136 studies
- Niet-kleincellige longkanker121 studies
- Kanker (alle vormen)109 studies
- Prostaatkanker103 studies
- Metastatische kanker93 studies
- Colorectale kanker78 studies
- Eierstokkanker69 studies
- Longkanker60 studies
- Multipel myeloom60 studies
- Aldermeesklierkanker60 studies
- Endometriumkanker52 studies
- Acute myeloïde leukemie51 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.